Enanta Pharmaceuticals, Inc. announced that the first patient had been dosed in RESOLVE, its global Phase 2b/3 clinical trial of zelicapavir in adults at high risk of severe outcomes from RSV ...

Documents released under the Official Information Act (OIA) show that WorkSafe nixed a plan to lower recommended exposure ...

Bolt Biotherapeutics has acquired Prana Therapies and announced US$120m in private financing to advance treatments for inflammatory diseases.

Use a True HEPA filter (H13 or H14 grade), which traps 99.97% of airborne particles down to 0.3 microns.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Global Phase 2b/3 Study Will Evaluate Symptom Duration and Hospitalization Rates in Adult Outpatients at High Risk of Severe Outcomes from RSV WATERTOWN, Mass. -- (BUSINESS WIRE)--Oct. 26, 2026-- ...

Dhaka is ranked the fourth most polluted city globally, with an AQI of 168. Air quality poses serious health risks, echoing ...

THE Filipino independent film, “2 Valid IDs,” starring Pokwang and Joey Marquez, tells a gripping tale of how ordinary Filipinos struggle to cope with poverty and bureaucratic red tape. Pokwang plays ...

Lycia Therapeutics went public with an upsized $317.5 million IPO on Friday, while immunology-focused Windward Bio has also seen which way the public markets are blowing. | Lycia Therapeutics went ...

Deborah Oliver was diagnosed with COPD, tissue disease and has experienced cardiac problems from two years' living on ...

Enanta doses the first patient in its Phase 2b/3 RESOLVE RSV trial of zelicapavir in high-risk adults, with initial topline ...

천식과 COPD의 공통점은 흡입기 치료가 중요하다는 점이지만, 처방의 핵심은 다르다. 천식에서는 ICS를 포함한 항염증 치료를 놓치지 않는 것, COPD에서는 장시간 작용 기관지확장제를 기반으로 하고 ICS를 필요한 환자에게 선별적으로 사용하는 것이 중요하다.